Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Edema: early-phase trial registry
5 of 14 indexed Edema trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 5 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Edema: 14 US clinical trials tracked, 5 recruiting.
Edema is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Church & Dwight Company, running 3 of these trials.
Enrollment posture brief
Registry condition edema
OPEN 5 | RECR 36% | LATE 1 | EARLY 3 | RANK #1230 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Attention (36% recruiting · 14 trials)
Edema lists 5 open slots (36% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Edema on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Edema is recruiting below its size-band peers.
5 of 14 indexed trials (35.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Edema research.
Church & Dwight Company accounts for 3 of 14 trials (21.4%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Edema trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 14 trials that report a genuine target (sentinel values excluded). 9 of those (64.3%) plan for fewer than 100 participants.
-
Edema research is mostly interventional.
11 interventional and 3 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University
NCT04278404
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
University of Michigan
NCT05505500
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Fibralign Corporation
NCT05695924
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
Fibralign Corporation
NCT04606030
Diuretic Tuner Clinical Decision Support
University of Texas Southwestern Medical Center
NCT04759274
Screening For BCRL In Targeted Therapy For Breast Cancer
Massachusetts General Hospital
NCT05142800
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
M.D. Anderson Cancer Center
NCT02411656
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
M.D. Anderson Cancer Center
NCT02876107
Human Repeat Insult Patch Test to Evaluate Personal Lubricants
Church & Dwight Company
NCT02737631
Foot and Ankle Post-operative Oedema Management Using Geko™
Firstkind
NCT04927234
Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers
Celtic Pharma Development Services
NCT00820092
A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects
Church & Dwight Company
NCT02737852
A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects
Church & Dwight Company
NCT02320214
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
Sarfez Pharmaceuticals
NCT06995144
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Edema records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Edema trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Edema page
14 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Edema trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Church & Dwight Company sponsors the most Edema trials on record, review their full trial history before evaluating a specific study. See Church & Dwight Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Edema condition card totals 14 registered trials; most-linked intervention Vascularized Lymph Node Transfer (VLNT); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.